Vaishali Pharma

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue20.6226.7713.7812.8728.37
Expenses17.0726.1511.6610.5025.50
EBITDA4.091.312.672.953.42
EBIT3.971.162.552.833.29
Profit Before Tax3.550.632.122.362.86
Net Profit2.660.441.591.702.11
Financial Ratios
Operating Profit Margin20.31%4.99%19.90%23.47%12.26%
Net Profit Margin13.24%1.68%11.85%13.52%7.56%
Earning Per Share (Diluted)2.520.061.411.521.89
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ